Julian Baker’s Wave Life Sciences WVE Stock Holding History

Julian Baker’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.78M	Hold	822,638	–	–	0.02%	76
2026 Q1	$5.96M	Buy	822,638 +478,575	+139%	+$6.23M	0.03%	72
2025 Q4	$5.85M	Hold	344,063	–	–	0.03%	72
2025 Q3	$2.52M	Hold	344,063	–	–	0.02%	79
2025 Q2	$2.24M	Hold	344,063	–	–	0.02%	75
2025 Q1	$2.78M	Hold	344,063	–	–	0.03%	70
2024 Q4	$4.26M	Hold	344,063	–	–	0.05%	73
2024 Q3	$2.82M	Buy	+344,063	New	+$2.06M	0.03%	79

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Julian Baker's WVE Position: Q2 2026 in Review

Julian Baker held its Wave Life Sciences (WVE) position steady in Q2 2026 at 822,638 shares worth $4.78M. The position accounts for 0.02% of the portfolio, ranked #76.

Julian Baker first reported a position in WVE in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.96M in Q1 2026. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Julian Baker held 822,638 shares of Wave Life Sciences worth $4.78M as of Q2 2026.
Julian Baker left its Wave Life Sciences share count unchanged in Q2 2026.
Wave Life Sciences made up 0.02% of Julian Baker's portfolio in Q2 2026, its #76 holding.
Julian Baker first reported a position in Wave Life Sciences in Q3 2024 and has held it in 8 quarters since.
Julian Baker's Wave Life Sciences position peaked at $5.96M in Q1 2026.
238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.